AURKB and thyroid gland carcinoma: It is interesting to note that inhibition of AURKB and ERK1/2, as opposed to other nodes of the MAPK pathway, most robustly inhibited growth in BRAFV600E mutant thyroid cancer cell lines (Figure 5).